Osteocytic oxygen sensing controls bone mass through epigenetic regulation of sclerostin

[1]  G. Carmeliet,et al.  The skeletal vascular system - Breathing life into bone tissue. , 2017, Bone.

[2]  Klaus Engelke,et al.  Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  P. Carmeliet,et al.  Adequate hypoxia inducible factor 1α signaling is indispensable for bone regeneration. , 2016, Bone.

[4]  M. Gassmann,et al.  Increased EPO Levels Are Associated With Bone Loss in Mice Lacking PHD2 in EPO‐Producing Cells , 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  P. Carmeliet,et al.  HIF-1α Promotes Glutamine-Mediated Redox Homeostasis and Glycogen-Dependent Bioenergetics to Support Postimplantation Bone Cell Survival. , 2016, Cell metabolism.

[6]  M. Amling,et al.  The Anti‐Osteoanabolic Function of Sclerostin Is Blunted in Mice Carrying a High Bone Mass Mutation of Lrp5 , 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  Marc N. Wein,et al.  The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro* , 2015, The Journal of Biological Chemistry.

[8]  E. Rankin,et al.  Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin , 2015, Genes & development.

[9]  Z. Bing,et al.  Dimethyloxalylglycine Prevents Bone Loss in Ovariectomized C57BL/6J Mice through Enhanced Angiogenesis and Osteogenesis , 2014, PloS one.

[10]  P. Kostenuik,et al.  Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin antibody administration to ovariectomized rats. , 2014, Bone.

[11]  Jan Schrooten,et al.  Expansion of Murine Periosteal Progenitor Cells with Fibroblast Growth Factor 2 Reveals an Intrinsic Endochondral Ossification Program Mediated by Bone Morphogenetic Protein 2 , 2014, Stem cells.

[12]  T. Bellido,et al.  The Sirtuin1 activator SRT3025 down-regulates sclerostin and rescues ovariectomy-induced bone loss and biomechanical deterioration in female mice. , 2014, Endocrinology.

[13]  J. Arbeit,et al.  Up-regulation of glycolytic metabolism is required for HIF1α-driven bone formation , 2014, Proceedings of the National Academy of Sciences.

[14]  R. Adams,et al.  Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone , 2014, Nature.

[15]  Sergei A. Vinogradov,et al.  Direct measurement of local oxygen concentration in the bone marrow of live animals , 2014, Nature.

[16]  Cesar Libanati,et al.  Romosozumab in postmenopausal women with low bone mineral density , 2014, The New England journal of medicine.

[17]  T. Martin,et al.  Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit. , 2014, BoneKEy reports.

[18]  L. Deng,et al.  Prolyl Hydroxylase Inhibitors Protect from the Bone Loss in Ovariectomy Rats by Increasing Bone Vascularity , 2014, Cell Biochemistry and Biophysics.

[19]  M. Almeida,et al.  The role of estrogen and androgen receptors in bone health and disease , 2013, Nature Reviews Endocrinology.

[20]  E. Canalis.  Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches , 2013, Nature Reviews Endocrinology.

[21]  Sarah L Dallas,et al.  The osteocyte: an endocrine cell ... and more. , 2013, Endocrine reviews.

[22]  Roland Baron,et al.  WNT signaling in bone homeostasis and disease: from human mutations to treatments , 2013, Nature Medicine.

[23]  L. Guarente,et al.  SIRT1 regulates differentiation of mesenchymal stem cells by deacetylating β-catenin , 2013, EMBO molecular medicine.

[24]  J. Kanis,et al.  Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  Jan Schrooten,et al.  Engineering Vascularized Bone: Osteogenic and Proangiogenic Potential of Murine Periosteal Cells , 2012, Stem cells.

[26]  G. Loots,et al.  Targeted deletion of Sost distal enhancer increases bone formation and bone mass , 2012, Proceedings of the National Academy of Sciences.

[27]  M. Ohh,et al.  The updated biology of hypoxia‐inducible factor , 2012, The EMBO journal.

[28]  J. Schrooten,et al.  Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization. , 2012, The Journal of clinical investigation.

[29]  E. Rankin,et al.  The HIF Signaling Pathway in Osteoblasts Directly Modulates Erythropoiesis through the Production of EPO , 2012, Cell.

[30]  Geert Carmeliet,et al.  Hypoxia-driven pathways in bone development, regeneration and disease , 2012, Nature Reviews Rheumatology.

[31]  Matthew R Allen,et al.  Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading. , 2012, Bone.

[32]  L. Bonewald,et al.  Cell line IDG‐SW3 replicates osteoblast‐to‐late‐osteocyte differentiation in vitro and accelerates bone formation in vivo , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  Lynda F. Bonewald,et al.  Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway , 2011, PloS one.

[34]  R Bogaerts,et al.  Development of micro-CT protocols for in vivo follow-up of mouse bone architecture without major radiation side effects. , 2011, Bone.

[35]  Kosaku Kurata,et al.  Evidence for osteocyte regulation of bone homeostasis through RANKL expression , 2011, Nature Medicine.

[36]  D. Toiber,et al.  Sirt1 is a regulator of bone mass and a repressor of Sost encoding for sclerostin, a bone formation inhibitor. , 2011, Endocrinology.

[37]  Jinhu Xiong,et al.  Matrix-embedded cells control osteoclast formation , 2011, Nature Medicine.

[38]  R. Chen,et al.  Hypoxia Increases Sirtuin 1 Expression in a Hypoxia-inducible Factor-dependent Manner* , 2011, The Journal of Biological Chemistry.

[39]  L. Bonewald,et al.  The Amazing Osteocyte , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[40]  Ralph Müller,et al.  Guidelines for assessment of bone microstructure in rodents using micro–computed tomography , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[41]  T. Clemens,et al.  Role of HIF‐1α in skeletal development , 2010, Annals of the New York Academy of Sciences.

[42]  Y. Mishina,et al.  Wnt Inhibitors Dkk1 and Sost Are Downstream Targets of BMP Signaling Through the Type IA Receptor (BMPRIA) in Osteoblasts , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[43]  M. Bouxsein,et al.  Hypoxia‐inducible factors 1α and 2α exert both distinct and overlapping functions in long bone development , 2010, Journal of cellular biochemistry.

[44]  Guoyin Feng,et al.  Sclerostin Mediates Bone Response to Mechanical Unloading Through Antagonizing Wnt/β‐Catenin Signaling , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[45]  Frederik De Smet,et al.  Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization , 2009, Cell.

[46]  R. Vennekens,et al.  TRPV4-mediated calcium influx regulates terminal differentiation of osteoclasts. , 2008, Cell metabolism.

[47]  P. Kostenuik,et al.  Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[48]  Matthew R Allen,et al.  Mechanical Stimulation of Bone in Vivo Reduces Osteocyte Expression of Sost/Sclerostin* , 2008, Journal of Biological Chemistry.

[49]  J. Myllyharju.  Prolyl 4-hydroxylases, key enzymes in the synthesis of collagens and regulation of the response to hypoxia, and their roles as treatment targets , 2008, Annals of medicine.

[50]  Chao Wan,et al.  The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. , 2007, The Journal of clinical investigation.

[51]  L. Bonewald,et al.  DMP1-targeted Cre Expression in Odontoblasts and Osteocytes , 2007, Journal of dental research.

[52]  R. Jilka,et al.  Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. , 2005, Endocrinology.

[53]  J. Reeve,et al.  The FASEB Journal express article 10.1096/fj.05-4221fje. Published online August 25, 2005. ©2005 FASEB , 2022 .

[54]  M. Kneissel,et al.  SOST is a target gene for PTH in bone. , 2005, Bone.

[55]  C. G. Bellows,et al.  Effect of simulated weightlessness on osteoprogenitor cell number and proliferation in young and adult rats. , 2005, Bone.

[56]  M. Karperien,et al.  Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP Antagonist , 2004, The Journal of experimental medicine.

[57]  John A Latham,et al.  Osteocyte control of bone formation via sclerostin, a novel BMP antagonist , 2003, The EMBO journal.

[58]  P. Ratcliffe,et al.  Regulation of angiogenesis by hypoxia: role of the HIF system , 2003, Nature Medicine.

[59]  Emily R Morey-Holton,et al.  Hindlimb unloading rodent model: technical aspects. , 2002, Journal of applied physiology.

[60]  P. Carmeliet,et al.  Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 , 2000, Mechanisms of Development.

[61]  Yanlei Hao,et al.  Hindlimb unloading rodent model : technical aspects , 2002 .

[62]  Michael I. Wilson,et al.  C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation , 2001, Cell.

[63]  Toshitaka Nakamura,et al.  Trabecular Bone Turnover and Bone Marrow Cell Development in Tail‐Suspended Mice , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[64]  D. Lewis,et al.  Technical aspects. , 1999, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[65]  G. Semenza,et al.  Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. , 1996, The American journal of physiology.

[66]  R. Albin.  Regeneration , 1993, Neurology.

[67]  J. Verhaeghe,et al.  Osteocalcin during the reproductive cycle in normal and diabetic rats. , 1989, The Journal of endocrinology.